Does This $10 Million Bet on New Oriental Education Stock Signal a Potential Turnaround Ahead?

Aubrey Capital Management disclosed a new $9.97 million position in New Oriental Education & Technology Group, buying 174,600 shares in Q1 and increasing its reportable AUM exposure by about 5%. The holding’s quarter-end value rose $9.89 million, aided by both the purchase and price movement, while EDU itself has delivered nearly 20% revenue growth in the latest quarter and 44.8% operating income growth. The filing is a constructive signal on the stock’s recovery and fundamentals, but the direct market impact is likely limited.

Analysis

The signal here is less about one manager’s conviction in EDU and more about what kind of capital is choosing Chinese education now: growth-oriented, fundamentals-aware allocators are willing to add exposure despite stale skepticism. That matters because the stock is no longer being bid purely on multiple expansion; if operating leverage keeps improving, incremental demand from a small set of concentrated holders can create a self-reinforcing rerating over the next 2-4 quarters. The second-order effect is that EDU becomes a cleaner read-through for whether investors are regaining comfort with consumer-facing China exposure more broadly, especially relative to internet and fintech proxies in the same portfolios.

The key risk is that this remains a policy-sensitive earnings recovery, not a de-risked compounder. Any tightening in China’s private education rhetoric, weaker outbound-study demand, or a pause in margin expansion would hit the stock harder than the broader market because current ownership appears to be anchored to a “quality recovery” narrative. In other words, the setup is favorable only as long as revenue growth and margin gains stay synchronized; if either decelerates for a single quarter, the market will likely reclassify the move as a value trap rather than a turnaround.

Contrarianly, the miss in the market may be underestimating how much optionality is embedded in the newer business mix. If adult education and adjacent initiatives keep scaling, EDU can surprise on earnings even without a return to old-line tutoring economics, which would justify a higher multiple than the market has been willing to assign. The cleanest framing is that the stock is not a momentum trade; it is a delayed-translation story where fundamentals have already turned, but sentiment still has to catch up.

EMBJ, NU, and EDU sitting together in the same portfolio also suggests this is an emerging-markets risk basket rather than a one-off bet, which increases the chance of correlated de-risking if macro volatility rises. That makes the trade more vulnerable to factor moves than company-specific disappointments, but also creates opportunity if EDU begins to decouple on earnings revisions. The asymmetry is strongest over the next 3-6 months, when the market will need to reconcile still-discounted sentiment with visibly improving operating metrics.

Key Decisions for Investors

• Go long EDU into the next earnings window with a 3-6 month horizon; upside comes from continued margin expansion and multiple rerating, while downside is capped if the stock merely tracks fundamentals. Best risk/reward if entered on weakness rather than chase strength.
• Use EDU as a relative-value long versus a China growth basket short, such as long EDU / short BABA or long EDU / short KWEB, to isolate company-specific operational momentum from broader China sentiment. This works best if EDU prints another quarter of double-digit growth while peers remain rangebound.
• For tactical upside, consider EDU call spreads 1-2 quarters out rather than outright stock, since the stock is likely to reprice on earnings revisions rather than immediate momentum. This limits policy headline risk while preserving convexity.
• If already long China internet exposure, pair EDU against a higher-beta China consumer name to reduce macro overlap and keep only the idiosyncratic recovery thesis. The point is to own the earnings inflection, not the broad EM beta.
• Set a hard stop if next quarter shows either revenue deceleration or margin compression; those are the two variables most likely to collapse the recovery narrative and compress the multiple quickly.